Analgesics in Italy

Analgesics in Italy

Analgesics is set to see a decline in retail value sales in current terms in Italy in 2024. The category’s performance was adversely affected by a peculiar flu season. Despite the record 14.5 million infections reported by RespiVirNet, the flu season showed an unusual pattern. In fact, the high number of infections was contrasted by a rather narrow time frame, with the peak concentrated at the end of December 2023. This led to a drop in analgesics sales as early as the second week of January. Th...

Euromonitor International's Analgesics in Italy report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.